OMAHA, NE—The most common form of inflammatory arthritis—gout—affects about eight million Americans. The disease causes intensely painful flares, but despite the availability of several drugs to manage this chronic, incurable condition, ongoing adherence to therapy... View Article
BOSTON – Despite fears of a rare but potentially fatal adverse reaction with use of allopurinol, the drug modestly reduces risk of death in patients with hyperuricemia and gout, according to a recent study. The... View Article
SAN DIEGO – Treating gouty arthritis is problematic in patients who have contraindications for, or are unresponsive or intolerant of, nonsteroidal antiinflammatory drugs (NSAIDs) or colchicine. A new study has found, however, that canakinumab (CAN),... View Article
© 2000-2017. All Materials Copyright Marathon Medical Communications, Inc.